📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit. (2014)

First Author: Tooth D

Attributed to: Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome(IBS-D) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/gutjnl-2012-304042

PubMed Identifier: 23911555

Publication URI: http://europepmc.org/abstract/MED/23911555

Type: Journal Article/Review

Volume: 63

Parent Publication: Gut

Issue: 5

ISSN: 0017-5749